TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 40 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,944 | +12.5% | 25,634 | +31.0% | 0.00% | 0.0% |
| Q1 2023 | $15,068 | -84.5% | 19,569 | -54.5% | 0.00% | -86.7% |
| Q4 2022 | $97,151 | +106.7% | 42,987 | +70.3% | 0.03% | +100.0% |
| Q3 2022 | $47,000 | -28.8% | 25,242 | +41.9% | 0.02% | -25.0% |
| Q2 2022 | $66,000 | -4.3% | 17,788 | +66.9% | 0.02% | +17.6% |
| Q1 2022 | $69,000 | – | 10,656 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,000,000 | $53,080,000 | 57.48% |
| Octagon Capital Advisors LP | 320,440 | $8,504,000 | 2.95% |
| Alphabet Inc. | 640,882 | $17,009,000 | 0.82% |
| Casdin Capital, LLC | 820,440 | $21,774,000 | 0.64% |
| Artal Group S.A. | 1,040,882 | $27,625,000 | 0.59% |
| VR Adviser, LLC | 107,982 | $2,866,000 | 0.42% |
| Avidity Partners Management LP | 392,000 | $10,404,000 | 0.34% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $13,270,000 | 0.28% |
| Perceptive Advisors | 470,440 | $12,485,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 250,000 | $6,635,000 | 0.13% |